about
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its recepto...
Read More
0.98
0.02
(2.08%)
151.8K
XNAS Volume
XNAS 12 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for InflaRx N.V. is on 20 Mar 2026 for the purpose of InflaRx NV Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
InflaRx N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..